Provided by Tiger Trade Technology Pte. Ltd.

Ocugen

1.02
+0.02002.00%
Volume:2.12M
Turnover:2.18M
Market Cap:345.29M
PE:-4.00
High:1.04
Open:1.04
Low:1.02
Close:1.00
52wk High:2.73
52wk Low:0.9700
Shares:338.52M
Float Shares:327.56M
Volume Ratio:0.55
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2551
EPS(LYR):-0.2260
ROE:-660.00%
ROA:-48.44%
PB:-20.86
PE(LYR):-4.51

Loading ...

Ocugen Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Aug 13

Ocugen Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Aug 11

Ocugen Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Aug 07

Ocugen, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Ocugen reports Q2 EPS (7c), consensus (5c)

TIPRANKS
·
Aug 06

Ocugen Q2 2026 earnings: Financing boosts cash while net loss widens

TradingKey
·
Aug 06

Ocugen Q2 FY26 Net Loss Widens to $24.88 Million; Revenue Rises to $1.49 Million

Reuters
·
Aug 06

Ocugen Q2 EPS USD -0.07

Reuters
·
Aug 06

Ocugen Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $1.488M Beat $888.833K Estimate

Benzinga Earnings
·
Aug 06

Ocugen Q2 Revenue USD 1.488 Million VS. Ibes Estimate USD 888.8 Thousand

THOMSON REUTERS
·
Aug 06

Ocugen Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Aug 06

Ocugen Inc Expected to Post a Loss of 5 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Ocugen Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Aug 04

Ocugen Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 01

Ocugen to Present Modifier Gene Therapy Platform at Oppenheimer Biotech Summit

Reuters
·
Jul 31

Ocugen to Participate in Upcoming August Investor Conferences

GlobeNewswire
·
Jul 31

Ocugen Announces Special Shareholder Meeting

Reuters
·
Jul 31

Ocugen Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jul 30

Ocugen - to Initiate Ocu410 Phase 3 Trial in Q3 2026, Bla Filing Anticipated in 2028

THOMSON REUTERS
·
Jul 29

Ocugen Announces That the U.S. Food and Drug Administration Has Granted Ocu410 Regenerative Medicine Advanced Therapy (Rmat) Designation for Treatment of Geographic Atrophy, Secondary to Dry Age-Related Macular Degeneration

THOMSON REUTERS
·
Jul 29